0.019956 0.011522 0.000000 0.000000 0.023044 0.000000 0.000000 0.000000 0.021219 0.00000 0.00000 0.00000 Johansson, K. Bourhis, J.-M. Campanacci, V. Cambillau, C. Canard, B. Longhi, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.00 90.00 120.00 50.109 50.109 47.127 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H11 N O2 Se 196.106 n SELENOMETHIONINE L-peptide linking C8 H17 N O3 S 207.290 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID N-CYCLOHEXYLTAURINE; CHES non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 278 44567 10.1074/JBC.M308745200 12944395 Crystal Structure of the Measles Virus Phosphoprotein Domain Responsible for the Induced Folding of the C-Terminal Domain of the Nucleoprotein 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100.0 1 CCD 2003-06-13 ADSC CCD SINGLE WAVELENGTH M x-ray 1 0.933 1.0 ID14-2 ESRF 0.933 SYNCHROTRON ESRF BEAMLINE ID14-2 6892.544 RNA POLYMERASE ALPHA SUBUNIT 2.7.7.48 XD-DOMAIN, RESIDUES 459-507 1 man polymer 207.290 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID 1 syn non-polymer 18.015 water 64 nat water PHOSPHOPROTEIN, NUCLEOCAPSID PHOSPHOPROTEIN no yes (MSE)ASRSVIRSIIKSSRLEEDRKRYL(MSE)TLLDDIKGANDLAKFHQ(MSE)LVKII(MSE)KHHHHHH MASRSVIRSIIKSSRLEEDRKRYLMTLLDDIKGANDLAKFHQMLVKIIMKHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n EDMONSTON B sample SELENOMETHIONINE 11234 MEASLES VIRUS 562 ESCHERICHIA COLI C41[DE3]PLYSS PDEST14 1 2.36 47.5 8.50 0.1 M CHES PH 8.5, 1.25 M NA CITRATE repository Initial release Version format compliance Version format compliance 1 0 2003-09-01 1 1 2011-05-08 1 2 2011-07-13 PDBE Y PDBE 2003-07-29 REL 1 A O HOH 2011 7.26 NHE 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID HOH water CATALYTIC ACTIVITY: N NUCLEOSIDE TRIPHOSPHATE = N DIPHOSPHATE + {RNA}(N). THIS CONFLICT IS DUE TO THE FACT THAT THE P GENE USED AS TEMPLATE TO AMPLIFY THE MEASLES VIRUS PHOSPHOPROTEIN XD GENE FRAGMENT IS THE PLASMID PSC6/P (RADECKE ET AL. EMBO, 1995) WHICH CONTAINS THIS MUTATION. HOWEVER, THIS MUTATED PHOSPHOPROTEIN IS FUNCTIONAL, AS INDICATED BY THE FACT THAT IT ALLOWS RESCUE OF MEASLES VIRUS IN A REVERSE GENETICS SYSTEM. NHE 1055 2 NHE NHE 1055 A HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2014 3 HOH HOH 2014 A HOH 2015 3 HOH HOH 2015 A HOH 2016 3 HOH HOH 2016 A HOH 2017 3 HOH HOH 2017 A HOH 2018 3 HOH HOH 2018 A HOH 2019 3 HOH HOH 2019 A HOH 2020 3 HOH HOH 2020 A HOH 2021 3 HOH HOH 2021 A HOH 2022 3 HOH HOH 2022 A HOH 2023 3 HOH HOH 2023 A HOH 2024 3 HOH HOH 2024 A HOH 2025 3 HOH HOH 2025 A HOH 2026 3 HOH HOH 2026 A HOH 2027 3 HOH HOH 2027 A HOH 2028 3 HOH HOH 2028 A HOH 2029 3 HOH HOH 2029 A HOH 2030 3 HOH HOH 2030 A HOH 2031 3 HOH HOH 2031 A HOH 2032 3 HOH HOH 2032 A HOH 2033 3 HOH HOH 2033 A HOH 2034 3 HOH HOH 2034 A HOH 2035 3 HOH HOH 2035 A HOH 2036 3 HOH HOH 2036 A HOH 2037 3 HOH HOH 2037 A HOH 2038 3 HOH HOH 2038 A HOH 2039 3 HOH HOH 2039 A HOH 2040 3 HOH HOH 2040 A HOH 2041 3 HOH HOH 2041 A HOH 2042 3 HOH HOH 2042 A HOH 2043 3 HOH HOH 2043 A HOH 2044 3 HOH HOH 2044 A HOH 2045 3 HOH HOH 2045 A HOH 2046 3 HOH HOH 2046 A HOH 2047 3 HOH HOH 2047 A HOH 2048 3 HOH HOH 2048 A HOH 2049 3 HOH HOH 2049 A HOH 2050 3 HOH HOH 2050 A HOH 2051 3 HOH HOH 2051 A HOH 2052 3 HOH HOH 2052 A HOH 2053 3 HOH HOH 2053 A HOH 2054 3 HOH HOH 2054 A HOH 2055 3 HOH HOH 2055 A HOH 2056 3 HOH HOH 2056 A HOH 2057 3 HOH HOH 2057 A HOH 2058 3 HOH HOH 2058 A HOH 2059 3 HOH HOH 2059 A HOH 2060 3 HOH HOH 2060 A HOH 2061 3 HOH HOH 2061 A HOH 2062 3 HOH HOH 2062 A HOH 2063 3 HOH HOH 2063 A HOH 2064 3 HOH HOH 2064 A n 1 1 A ALA 2 n 2 ALA 2 A SER 3 n 3 SER 3 A ARG 4 n 4 ARG 4 A SER 5 n 5 SER 5 A VAL 6 n 6 VAL 6 A ILE 7 n 7 ILE 7 A ARG 8 n 8 ARG 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A ILE 11 n 11 ILE 11 A LYS 12 n 12 LYS 12 A SER 13 n 13 SER 13 A SER 14 n 14 SER 14 A ARG 15 n 15 ARG 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A GLU 18 n 18 GLU 18 A ASP 19 n 19 ASP 19 A ARG 20 n 20 ARG 20 A LYS 21 n 21 LYS 21 A ARG 22 n 22 ARG 22 A TYR 23 n 23 TYR 23 A LEU 24 n 24 LEU 24 A MSE 25 n 25 MSE 25 A THR 26 n 26 THR 26 A LEU 27 n 27 LEU 27 A LEU 28 n 28 LEU 28 A ASP 29 n 29 ASP 29 A ASP 30 n 30 ASP 30 A ILE 31 n 31 ILE 31 A LYS 32 n 32 LYS 32 A GLY 33 n 33 GLY 33 A ALA 34 n 34 ALA 34 A ASN 35 n 35 ASN 35 A ASP 36 n 36 ASP 36 A LEU 37 n 37 LEU 37 A ALA 38 n 38 ALA 38 A LYS 39 n 39 LYS 39 A PHE 40 n 40 PHE 40 A HIS 41 n 41 HIS 41 A GLN 42 n 42 GLN 42 A MSE 43 n 43 MSE 43 A LEU 44 n 44 LEU 44 A VAL 45 n 45 VAL 45 A LYS 46 n 46 LYS 46 A ILE 47 n 47 ILE 47 A ILE 48 n 48 ILE 48 A MSE 49 n 49 MSE 49 A LYS 50 n 50 LYS 50 A HIS 51 n 51 HIS 51 A HIS 52 n 52 HIS 52 A HIS 53 n 53 HIS 53 A HIS 54 n 54 HIS 54 A HIS 55 n 55 HIS 55 A n 56 56 A author_and_software_defined_assembly PQS 1 monomeric A MSE 25 SELENOMETHIONINE A MSE 25 MET A MSE 43 SELENOMETHIONINE A MSE 43 MET A MSE 49 SELENOMETHIONINE A MSE 49 MET 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CA HIS 55 A CA HIS 55 1 Y 1 A C HIS 55 A C HIS 55 1 Y 1 A O HIS 55 A O HIS 55 1 Y 1 A CB HIS 55 A CB HIS 55 1 Y 1 A CG HIS 55 A CG HIS 55 1 Y 1 A ND1 HIS 55 A ND1 HIS 55 1 Y 1 A CD2 HIS 55 A CD2 HIS 55 1 Y 1 A CE1 HIS 55 A CE1 HIS 55 1 Y 1 A NE2 HIS 55 A NE2 HIS 55 1 Y 1 A MSE 1 A MSE 1 1 Y 1 A HIS 56 A HIS 56 1 Y 1 A A SE CE MSE MSE 25 25 -0.380 0.059 1.950 1.570 N 35.76 1.34000 0.67000 0.00000 1.34000 0.00000 -2.01000 0.961 0.949 0.239 0.198 0.200 1.80 12.00 310 6291 4.700 99.8 3.323 0.099 RANDOM 1 THROUGHOUT SIRAS 0.127 0.126 0.80 0.80 1.40 MAXIMUM LIKELIHOOD BABINET MODEL WITH MASK 1.80 12.00 64 517 13 0 440 0.024 0.021 459 1.502 1.980 609 4.483 5.000 52 0.010 0.020 321 0.226 0.200 216 0.181 0.200 30 0.153 0.200 21 0.200 0.200 15 1.857 1.500 266 3.207 2.000 428 5.632 3.000 193 7.899 4.500 181 0.3650 0.2840 1.85 23 458 20 1.800 12.000 1OKS 6611 0.05200 1 6.5000 6.800 99.6 0.47200 1.80 1.90 1.600 1 6.90 100.0 refinement REFMAC 5.1.24 data reduction MOSFLM data scaling SCALA RNA POLYMERASE ALPHA SUBUNIT (E.C.2.7.7.48) Crystal structure of the measles virus phosphoprotein XD domain 1 N N 2 N N 3 N N A SER 3 A SER 3 HELX_P A SER 14 A SER 14 1 1 12 A GLU 17 A GLU 17 HELX_P A ILE 31 A ILE 31 1 2 15 A GLY 33 A GLY 33 HELX_P A GLN 42 A GLN 42 1 3 10 A LEU 44 A LEU 44 HELX_P A HIS 53 A HIS 53 1 4 10 covale 1.327 A LEU 24 A C LEU 24 1_555 A MSE 25 A N MSE 25 1_555 covale 1.339 A MSE 25 A C MSE 25 1_555 A THR 26 A N THR 26 1_555 covale 1.339 A GLN 42 A C GLN 42 1_555 A MSE 43 A N MSE 43 1_555 covale 1.330 A MSE 43 A C MSE 43 1_555 A LEU 44 A N LEU 44 1_555 covale 1.326 A ILE 48 A C ILE 48 1_555 A MSE 49 A N MSE 49 1_555 covale 1.328 A MSE 49 A C MSE 49 1_555 A LYS 50 A N LYS 50 1_555 TRANSFERASE TRANSFERASE, RNA-DIRECTED RNA POLYMERASE, NUCLEOCAPSID, PHOSPHORYLATION. 1OKS PDB 1 1OKS P03422 UNP 1 P03422 1 1 1OKS 1 1 1OKS A 1 1 1 459 507 1OKS 2 50 P03422 A 2 2 50 51 56 1OKS 51 56 1OKS A 1 51 56 1 MET conflict VAL 45 1OKS A P03422 UNP 502 45 BINDING SITE FOR RESIDUE NHE A1055 Software 8 A ARG 20 A ARG 20 8 1_555 A TYR 23 A TYR 23 8 1_555 A HIS 41 A HIS 41 8 1_555 A VAL 45 A VAL 45 8 1_555 A ILE 47 A ILE 47 8 1_555 A HIS 51 A HIS 51 8 1_555 A HOH 2031 C HOH 8 1_555 A HOH 2064 C HOH 8 1_555 154 P 32 2 1